| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Sohn Catherine A. serves as a Director at PALI and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 3 buys and 13 sells. Those positions are worth an estimated $2.6M at current prices.
Historically, Sohn Catherine A.'s trades have earned a middling insider score of 55/100 across 7 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -2.2%.
The biggest single holding is JAZZ (~$2.1M) as Director. The recent filings there lean toward selling, a net 19,748 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | MAZE Maze Therapeutics, Inc. | Director | Sale+OE | 29,413 | $39.07 | $1,149,054.36 | - | -29.8% | - | |
| Jan 5, 2026 | ALT Altimmune, Inc. | Director | Buy | 500 | $4.24 | $2,117.55 | +50.0% | -18.6% | - | |
| Mar 17, 2025 | ALT Altimmune, Inc. | Director | Buy | 1,000 | $5.78 | $5,784.50 | New | +15.1% | -40.9% | |
| Aug 14, 2023 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 1,241 | $138.16 | $171,454.70 | -7.7% | -12.9% | -20.2% | |
| Aug 8, 2022 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 1,089 | $152.32 | $165,879.64 | -7.7% | -5.7% | -14.2% | |
| Aug 6, 2021 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 1,306 | $147.96 | $193,235.76 | -10.1% | -11.0% | +2.5% | |
| Nov 4, 2020 | JAZZ Jazz Pharmaceuticals Plc | Director | Sale+OE | 12,500 | $153.44 | $1,918,000.00 | -54.1% | - | - | |
| Aug 7, 2020 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 931 | $125.87 | $117,185.71 | -8.1% | - | - | |
| Aug 9, 2019 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 726 | $135.65 | $98,482.12 | -7.6% | - | - | |
| Jan 10, 2019 | LFCR Lifecore Biomedical, Inc. \de\ | Director | Buy | 1,000 | $11.23 | $11,230.00 | +4.2% | - | - |